These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Structural considerations of plasmic degradation of fibrinogen. Marder VJ; Budzynski AZ Pathol Biol (Paris); 1974 Nov; 22 suppl():43-6. PubMed ID: 4283397 [No Abstract] [Full Text] [Related]
24. [An analysis of disseminated intravascular coagulation by fibrinopeptides]. Gando S; Tedo I Rinsho Ketsueki; 1988 Dec; 29(12):2250-5. PubMed ID: 3150013 [No Abstract] [Full Text] [Related]
25. Activation of blood coagulation and fibrinolysis in Graves' disease. Marongiu F; Conti M; Murtas ML; Mameli G; Sorano GG; Martino E Horm Metab Res; 1991 Dec; 23(12):609-11. PubMed ID: 1778596 [TBL] [Abstract][Full Text] [Related]
26. The action of Russell's viper venom on fibrin formation and fibrinolysis in vivo. Woodhams BJ; Than T; Than T; Hutton RA Br J Haematol; 1989 Jan; 71(1):107-11. PubMed ID: 2492816 [TBL] [Abstract][Full Text] [Related]
27. [Clinical tests on the diagnosis of thrombosis]. Yamanaka M Nihon Rinsho; 1986 May; 44(5):1076-80. PubMed ID: 2943914 [No Abstract] [Full Text] [Related]
28. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease. Hughes RD; Lane DA; Ireland H; Langley PG; Gimson AE; Williams R Clin Sci (Lond); 1985 Jun; 68(6):701-7. PubMed ID: 2485273 [TBL] [Abstract][Full Text] [Related]
29. [Molecular markers of hemostatic mechanisms--fibrinopeptide A and fibrinopeptide B beta 15-42]. Kobayashi N Rinsho Byori; 1989 Mar; 37(3):231-3. PubMed ID: 2746916 [No Abstract] [Full Text] [Related]
30. Thrombin and plasmin activity in coronary artery disease. Small M; Lowe GD; Douglas JT; Hutton I; Lorimer AR; Forbes CD Br Heart J; 1988 Sep; 60(3):201-3. PubMed ID: 2972304 [TBL] [Abstract][Full Text] [Related]
31. [New clinical tests in diagnosis of hematologic diseases]. Nakahara K Nihon Naika Gakkai Zasshi; 1993 Apr; 82(4):529-33. PubMed ID: 8340662 [No Abstract] [Full Text] [Related]
32. [Molecular markers of hemostatic mechanisms--fibrinopeptide B beta 1-42]. Kuroso K Rinsho Byori; 1989 Mar; 37(3):234-9. PubMed ID: 2664279 [No Abstract] [Full Text] [Related]
34. [Fibrinopeptide A (FPA) and fibrinopeptide B beta 15-42 (FPB beta 15-42)]. Tatsumi N; Hirai N; Tatsumi Y Nihon Rinsho; 1995 Mar; 53 Su Pt 2():39-42. PubMed ID: 8753175 [No Abstract] [Full Text] [Related]
35. Diagnostic and prognostic value of fibrinopeptides in patients with clinically suspected pulmonary embolism. Gando S; Tedo I Thromb Res; 1994 Jul; 75(2):195-202. PubMed ID: 7974393 [TBL] [Abstract][Full Text] [Related]
36. Unique pattern of fibrinogen cleavage by human leukocyte proteases. Bilezikian SB; Nossel HL Blood; 1977 Jul; 50(1):21-8. PubMed ID: 871524 [No Abstract] [Full Text] [Related]
37. [Coagulation-fibrinolysis system on pregnant toxicosis]. Yoshida A; Morozumi K; Shinmura I; Oikawa T; Gotoh I; Fujimami T; Yagami Y Nihon Jinzo Gakkai Shi; 1986 Oct; 28(10):1345-52. PubMed ID: 3820811 [No Abstract] [Full Text] [Related]
38. Postoperative changes in hemostasis analyzed by the serial determination of fibrinopeptides and D-dimer. Kang J; Kambayashi J; Sakon M; Tsujinaka T; Mori T Jpn J Surg; 1989 May; 19(3):262-8. PubMed ID: 2674499 [TBL] [Abstract][Full Text] [Related]
39. [Functional and diagnostic significance of A-, Bbeta 1-42 and Bbeta 15-42 peptide fragments of fibrin(ogen)]. Makogonenko EM; Lugovskoĭ EV; Kolesnik LA; Kudinov SA Ukr Biokhim Zh (1978); 1992; 64(4):78-82. PubMed ID: 1448878 [TBL] [Abstract][Full Text] [Related]
40. [Coagulation-fibrinolysis abnormalities in acute stage of subarachnoid hemorrhage (Part 1)--With special reference to the relation between cerebral vasospasm and fibrinopeptides A and B beta]. Touho H; Hino A; Suzuki K; Kubo T; Hirakawa K No To Shinkei; 1984 Oct; 36(10):1009-14. PubMed ID: 6518124 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]